[1] Takahiro Y,Eiju N,Shinji K,et al. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/ cytosolic 5'-nucleotidase Ⅱ expression ratio in primary acute myeloid leukemia cells[J]. Biochem Pharmacol,2009, 77 (12): 1780-1786. [2] Chiang CT,Yeh PY,Gao M,et al. Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma[J]. Cancer Lett,2010,298(2):195-203. [3] Bray MS,Boerwinkle E,Doris PA. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: problems and promise[J]. Hum Mutat,2001,17:296-304. [4] Shi JY,Shi ZZ,Zhang SJ,et al. Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients[J]. Pharmaco-genetics,2004,14(11):759-768. [5] Joerger M,Bosch TM,Doodeman VD,et al. Novel deoxycyti-dine kinase gene polymorphisms:a population screening study in Caucasian healthy volunteers[J]. Eur J Clin Pharmacol, 2006,62(8):681-684. [6] 岳丽杰,陈小文,李成荣,等. 中国急性白血病儿童与正常儿童cDNA基因多态性研究[J]. 中华医学遗传学杂志,2007,24(6):699-702. [7] 陈小文,岳丽杰,李成荣,等. 胞苷脱氨酶基因多态性与阿糖胞苷敏感性关系的研究[J]. 中华血液学杂志,2008, 29(7):459-463. [8] Guex N,Peitsch MC. Swiss-Model and the Swiss-Pdb-Viewer: an environment for comparative protein modeling[J]. Electrop-horesis,1997,18(15):2714-2723. [9] Xu PP,Chen BA,Feng JF,et al. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia[J]. Chin Med J,2012,125(12):2137-2143. |